-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ampio Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Ampio Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$2.05M, a 7.48% increase year-over-year.
- Ampio Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$8.63M, a 47.2% increase year-over-year.
- Ampio Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.63M, a 47.2% increase from 2022.
- Ampio Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$16.3M, a 4.32% increase from 2021.
- Ampio Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.1M, a 7.43% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)